Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pEGFP-TRAIL Citations (14)

Originally described in: Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene.
Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA, Curley SA, Stephens LC, Fang B Cancer Res. 2001 Apr 15. 61(8):3330-8. PubMed

Articles Citing pEGFP-TRAIL

Articles
Tumor cell-selective apoptosis induction through targeting of K(V)10.1 via bifunctional TRAIL antibody. Hartung F, Stuhmer W, Pardo LA. Mol Cancer. 2011 Sep 7;10:109. doi: 10.1186/1476-4598-10-109. PubMed
Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome. Sun X, Pang Z, Ye H, Qiu B, Guo L, Li J, Ren J, Qian Y, Zhang Q, Chen J, Jiang X. Biomaterials. 2012 Jan;33(3):916-24. doi: 10.1016/j.biomaterials.2011.10.035. Epub 2011 Nov 1. PubMed
MSC(TRAIL)-mediated HepG2 cell death in direct and indirect co-cultures. Sun XY, Nong J, Qin K, Lu H, Moniri MR, Dai LJ, Warnock GL. Anticancer Res. 2011 Nov;31(11):3705-12. PubMed
Ratio of phosphorylated HSP27 to nonphosphorylated HSP27 biphasically acts as a determinant of cellular fate in gemcitabine-resistant pancreatic cancer cells. Kang D, Choi HJ, Kang S, Kim SY, Hwang YS, Je S, Han Z, Kim JH, Song JJ. Cell Signal. 2015 Apr;27(4):807-17. doi: 10.1016/j.cellsig.2015.01.007. Epub 2015 Jan 20. PubMed
Silencing Daxx increases the anti-tumor activity of a TRAIL/shRNA Bcl-xL-expressing oncolytic adenovirus through enhanced viral replication and cellular arrest. Kang S, Kang D, Bakhtiar Ul Islam SM, Je S, Kim JH, Song JJ. Cell Signal. 2015 Jun;27(6):1214-24. doi: 10.1016/j.cellsig.2015.02.028. Epub 2015 Mar 5. PubMed
Nanoparticle-Mediated Target Delivery of TRAIL as Gene Therapy for Glioblastoma. Wang K, Kievit FM, Jeon M, Silber JR, Ellenbogen RG, Zhang M. Adv Healthc Mater. 2015 Dec;4(17):2719-26. doi: 10.1002/adhm.201500563. Epub 2015 Oct 26. PubMed
Survivin silencing and TRAIL expression using oncolytic adenovirus increase anti-tumorigenic activity in gemcitabine-resistant pancreatic cancer cells. Han Z, Lee S, Je S, Eom CY, Choi HJ, Song JJ, Kim JH. Apoptosis. 2015 Dec 16. PubMed
PTEN and TRAIL genes loaded zein nanoparticles as potential therapy for hepatocellular carcinoma. El Sharkawi FZ, Ewais SM, Fahmy RH, Rashed LA. J Drug Target. 2017 Jul;25(6):513-522. doi: 10.1080/1061186X.2017.1289536. Epub 2017 Feb 16. PubMed
Polymeric nanoparticle-based delivery of TRAIL DNA for cancer-specific killing. Tzeng SY, Wilson DR, Hansen SK, Quinones-Hinojosa A, Green JJ. Bioeng Transl Med. 2016 Jun;1(2):149-159. doi: 10.1002/btm2.10019. PubMed
In Vitro Effects of Mesenchymal Stem Cells and Various Agents on Apoptosis of Glioblastoma Cells. Tanrikulu B, Ziyal I, Bayri Y. Turk Neurosurg. 2019;29(1):26-32. doi: 10.5137/1019-5149.JTN.21827-17.2. PubMed
TRAIL-secreting human mesenchymal stem cells engineered by a non-viral vector and photochemical internalization for pancreatic cancer gene therapy. Han J, Hwang HS, Na K. Biomaterials. 2018 Nov;182:259-268. doi: 10.1016/j.biomaterials.2018.08.024. Epub 2018 Aug 9. PubMed
Sonoporation by microbubbles as gene therapy approach against liver cancer. Rinaldi L, Folliero V, Palomba L, Zannella C, Isticato R, Di Francia R, Berretta M, de Sio I, Adinolfi LE, Morelli G, Lastoria S, Altucci L, Pedone C, Galdiero M, Franci G. Oncotarget. 2018 Aug 14;9(63):32182-32190. doi: 10.18632/oncotarget.25875. eCollection 2018 Aug 14. PubMed
Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma. Malik YS, Sheikh MA, Xing Z, Guo Z, Zhu X, Tian H, Chen X. Acta Biomater. 2018 Oct 15;80:144-153. doi: 10.1016/j.actbio.2018.09.015. Epub 2018 Sep 15. PubMed
Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer. Vaughan HJ, Zamboni CG, Radant NP, Bhardwaj P, Revai Lechtich E, Hassan LF, Shah K, Green JJ. Mol Ther Oncolytics. 2021 Apr 16;21:377-388. doi: 10.1016/j.omto.2021.04.004. eCollection 2021 Jun 25. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.